GRHL1 inhibitors belong to a specialized class of chemical compounds designed to modulate the activity of the Grainyhead-like transcription factor 1 (GRHL1). GRHL1 is a member of the Grainyhead family of transcription factors, which play crucial roles in various cellular processes, including epithelial development, wound healing, and tissue repair. The transcription factor GRHL1, in particular, is known for its involvement in the regulation of epithelial-mesenchymal transition (EMT), a biological process crucial for embryonic development and tissue homeostasis. EMT is characterized by the transformation of epithelial cells into mesenchymal cells, facilitating cell migration and tissue remodeling.
Inhibitors targeting GRHL1 function operate by specifically binding to the active site of the transcription factor, thereby modulating its activity and influencing downstream gene expression. The modulation of GRHL1 activity is of particular interest due to its implications in cellular plasticity and its involvement in various physiological and pathological processes. By selectively inhibiting GRHL1, these compounds provide researchers with a valuable tool to investigate the intricate regulatory networks associated with epithelial biology and EMT. Understanding the molecular mechanisms controlled by GRHL1 inhibitors could unveil insights into developmental processes, tissue regeneration, and potentially offer new avenues for exploring cellular dynamics in the context of various diseases.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin can modulate multiple signaling pathways, potentially altering GRHL1 transcriptional activity. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol influences various signaling pathways, which may affect GRHL1 function indirectly. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, as a tyrosine kinase inhibitor, may alter phosphorylation cascades related to GRHL1 activity. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin impacts kinase signaling and could modify GRHL1-related pathways. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Sulforaphane can affect transcription factors and their signaling, potentially influencing GRHL1. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG affects various signaling pathways that might modulate GRHL1-related functions. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, may disrupt pathways upstream of GRHL1 regulation. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059, an MEK inhibitor, could affect MAPK/ERK pathway, potentially altering GRHL1 activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125, a JNK inhibitor, might influence signaling pathways associated with GRHL1. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which can be linked to transcriptional regulation pathways involving GRHL1. | ||||||